Professor Anthony Zulli was a co-first author together with Martin Caprnda of The therapeutic effect of B-type natriuretic peptides in acute decompensated heart failure, to review the clinical data on B-type natriuretic peptides (BNP) for the treatment of acute heart failure. Despite the potential for BNP to treat renal failure, several clinical trials of the treatment have failed to demonstrate beneficial outcomes. The review of the clinical data, funded by the Czech Science Foundation, was to establish a detailed understanding of the mechanism of BNP and a better integration of basic and clinical science, involved a team of seventeen researchers from: Slovakia, Australia, United Kingdom, Norway, Romania, Lithuania, Czech Republic and Canada.
The Mitchell Institute released the national policy blueprint Self-Care For Health. The policy blueprint presents nine priorities to support self-care and improve the underlying factors linked to disparate health outcomes for well resourced versus disadvantaged communities. The report launched by the Federal Minister for Health, Honourable Greg Hunt MP, was developed by seven expert working groups developed the blueprint, involving researchers and authorities from Australian and international universities and government and non-government health organisations, including the World Health Organization.
Professor Vasso Apostolopoulos collaborated with an international team of researchers for The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19.
Professors Željko Pedišić and Stuart Biddle joined with five other researchers from five countries to review National physical activity and sedentary behaviour policies in 76 countries: availability, comprehensiveness, implementation, and effectiveness.
Closer to home, Professor Pedišić was a contributing author to the Getting Australia Active III policy report to the Australian Department of Health. The report was prepared by The Australian Prevention Partnership Centre, a national collaboration of researchers, policy makers and practitioners who are working together to identify new ways of understanding what works and what doesn’t to prevent lifestyle-related chronic health problems in Australia.
A team of seven researchers from IHES – Tawar Qaradakhi, Laura Kate Gadanec, Kristen Renee McSweeney, Alexander Tacey, Vasso Apostolopoulos, Itamar Levinger and Anthony Zulli – collaborated with researchers from Slovakia, Canada, Spain and the Czech Republic to establish the potential for the use of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in the treatment of cardiovascular, cancer, diabetes and other chronic diseases.